The study aims to evaluate whether intracisternal administration of APOE2 to APOE4 homozygotes AD patients will lead to conversion of the APOE protein isoforms from APOE4 homozygotes to APOE2–APOE4, which has given positive results in mice and monkeys previously [261,262]. Here, APOE is linked to Alzheimer disease.